Overstock and Siebert Financial Launch Discount Online Equities Trading
Feb 06, 2018 12:00 pm UTC| Business
SALT LAKE CITY, Feb. 06, 2018 -- Overstock.com, Inc. (NASDAQ:OSTK) and Siebert Financial Corp. (NASDAQ:SIEB) announce the launch of the Muriel Siebert Co. Inc. (Siebert) discounted online trading platform through...
Leap Therapeutics to Present at the 20th Annual BIO CEO & Investor Conference
Feb 06, 2018 12:00 pm UTC| Business
CAMBRIDGE, Mass., Feb. 06, 2018 -- Leap Therapeutics, Inc. (NASDAQ:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Douglas E. Onsi, Chief Financial Officer, will...
Mitek Official Identity Verification Provider to Mobile World Congress 2018
Feb 06, 2018 12:00 pm UTC| Business
SAN DIEGO and LONDON, Feb. 06, 2018 -- Mitek (NASDAQ:MITK), a global leader in mobile capture and identity verification software solutions, today announced that it is the official identity verification provider to the...
Feb 06, 2018 12:00 pm UTC| Business
RICHARDSON, Texas, Feb. 06, 2018 -- Fossil Group, Inc. (NASDAQ:FOSL) announced today that its earnings for its fourth quarter and fiscal year ended December 30, 2017 will be released following the market close on...
Sonic Foundry Announces NewTek NDI Integration
Feb 06, 2018 12:00 pm UTC| Business
AMSTERDAM, The Netherlands, ISE Stand #11-D150, Feb. 06, 2018 -- Sonic Foundry, Inc. (NASDAQ: SOFO), the trusted global leader for video creation and management solutions, announces integration between Mediasite video...
Amplience Shares Best Practices for Developing and Executing Effective Retail Engagement Strategies
Feb 06, 2018 12:00 pm UTC| Business
NEW YORK, Feb. 06, 2018 -- Amplience today announced that registration is open for the company’s 2018 Retail Engagement Summits. Taking place in New York on February 22nd and London on March 6th, the Summits will tackle...
Feb 06, 2018 12:00 pm UTC| Business
The final three Paroxysmal Nocturnal Hemoglobinuria (PNH) patients enrolled into the Phase II COBALT trial with the revised dosing regimen had median LDH of 1.5 times the ULN at Day 28, 60 and 90 Phase III clinical trial...